20
Feb
Optogenerapy team starts working on bio-electronic implants to treat Multiple Sclerosis
in Meeting
Comments
Barcelona 20th February, 2017 - Researchers from eleven institutions and companies in seven different European countries met at Eurecat’s facilities in Cerdanyola del Vallès (Barcelona) to launch the Optogenerapy project, which aims to develop optogenetic cellular therapy implants as a new treatment for Multiple Sclerosis. The devices, based on technology developed at the Swiss Federal Institute of Technology in Basel, member of the consortium, will enable the...
Read More